Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

China flag China · Delayed Price · Currency is CNY
17.49
-0.17 (-0.96%)
At close: Dec 12, 2025
2.70%
Market Cap29.22B
Revenue (ttm)6.01B
Net Income (ttm)-278.89M
Shares Out1.67B
EPS (ttm)-0.17
PE Ration/a
Forward PE23.80
Dividend0.60 (3.43%)
Ex-Dividend DateOct 22, 2025
Volume26,861,270
Average Volume35,429,144
Open17.59
Previous Close17.66
Day's Range17.30 - 17.69
52-Week Range12.41 - 21.58
Beta0.66
RSI40.06
Earnings DateApr 29, 2026

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is base... [Read more]

Sector Healthcare
Founded 1992
Employees 11,708
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002603
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.